F S&P 500
5,251.00 +12.00 (+0.23%) F Dow Jones
39,607.00 +71.00 (+0.18%) F Nasdaq
18,264.00 +49.50 (+0.27%) E-mini Russell 2000 Index Futur
2,091.30 +7.20 (+0.35%) Petróleo
79.53 +0.27 (+0.34%) Oro
2,375.90 +35.60 (+1.52%)
MabCure, Inc. (MBCI)
MabCure, Inc.
21 Sparrow Circle
White Plains, NY 10605
United States
845 591 3144
Sector(es): Technology
Industria: Solar
Empleados a tiempo completo: 3
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Jehu Thomas Degerold Hand | Chief Executive & Financial Officer and Director | N/D | N/D | 1957 |
Descripción
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
Gestión corporativa
La calificación ISS Governance QuickScore de MabCure, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
